[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100388846":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":21,"centralContacts":25,"locations":31,"responsibleParty":49,"collaborators":53,"id":59,"slug":60,"hasResults":61,"nctId":62,"briefTitle":63,"officialTitle":64,"acronym":65,"eligibilityCriteria":66,"healthyVolunteers":61,"sex":67,"minAge":68,"maxAge":20,"enrollmentInfo":69,"targetDuration":20,"studyType":72,"phases":73,"briefSummary":18,"conditions":75,"keywords":20,"overallStatus":34,"whyStopped":20,"lastUpdateSubmitDate":79,"lastUpdatePostDateStruct":80,"startDateStruct":83,"completionDateStruct":85,"leadSponsor":87,"locationsCount":88},{"fullName":5,"class":6},"University of California, San Diego","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Image-guided cognitive sparing brain SRS","EXPERIMENTAL","This is a single arm phase II study where enrolled subjects will receive intracranial SRS will performed identically to standard of care, except for implementing additional imaging techniques and software for additional regional avoidance for cognitive sparing (specifically sparing white matter and the bilateral hippocampus)",[13],"Radiation: Cognitive Sparing Brain Stereotactic Radiosurgery (SRS)",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"RADIATION","Cognitive Sparing Brain Stereotactic Radiosurgery (SRS)","In this proposal, the investigators introduce advanced diffusion and volumetric imaging techniques along with innovative, automated image parcellation methods to identify critical brain regions, incorporate into cognitive-sparing SRS, and analyze biomarkers of radiation response. This work will advance the investigators' understanding of neurocognitive changes after brain SRS and help create interventions that preserve cognitive-function in brain metastases patients.",[9],null,[22],{"name":23,"affiliation":5,"role":24},"Jona Hattangadi-Gluth, MD","PRINCIPAL_INVESTIGATOR",[26],{"name":27,"role":28,"phone":29,"phoneExt":20,"email":30},"Sheila Medina","CONTACT","858-822-6575","s4medina@health.ucsd.edu",[32],{"facility":33,"status":34,"city":35,"state":36,"zip":37,"country":38,"countryCode":39,"cosmosGeoPoint":40,"geoPoint":45,"contacts":46},"Moores Cancer Center","RECRUITING","San Diego","California","92037","United States","US",{"type":41,"coordinates":42},"Point",[43,44],-117.16472,32.71571,{"lat":44,"lon":43},[47,48],{"name":27,"role":28,"phone":29,"phoneExt":20,"email":30},{"name":23,"role":24,"phone":20,"phoneExt":20,"email":20},{"type":50,"investigatorFullName":51,"investigatorTitle":52,"investigatorAffiliation":5,"oldNameTitle":20,"oldOrganization":20},"SPONSOR_INVESTIGATOR","Jona Hattangadi-Gluth","Associate Clinical Professor",[54,57],{"name":55,"class":56},"National Institutes of Health (NIH)","NIH",{"name":58,"class":56},"National Cancer Institute (NCI)","100388846","phase-2-ucsd-image-guided-cognitive-sparing-radiosurgery-for-brain-metastases-100388846",false,"NCT04343157","UCSD Image-Guided Cognitive-Sparing Radiosurgery for Brain Metastases","UCSD Image-Guided Cognitive-Sparing Radiosurgery for Brain Metastases: Avoidance of Eloquent White Matter and Hippocampal Regions","IG-SRS","Inclusion Criteria:\n\n1. Patients 18 years or older\n2. One to three brain metastases targets, all smaller than 3 cm in diameter (intact or resected tumor bed)\n3. Eastern cooperative Oncology Group (ECOG) performance status 0-2 (score of 0, no symptoms; 1, mild symptoms; 2, symptomatic, \\\u003C50% in bed during the day)\n4. Ability to answer questions and follow commands via neurocognitive testing\n5. Estimated life expectancy greater than 6 months\n6. Pathologic confirmation of extracerebral tumor site (eg, lung, breast, prostate) from either the primary site or a metastatic lesion\n7. Willingness\u002FAbility to undergo brain MRI scans\n8. Able to give informed consent\n\nExclusion Criteria:\n\n1. Pregnant or nursing women\n2. Women of childbearing potential unwilling to use adequate contraception\n3. Inability to complete a magnetic resonance imaging scan with contrast\n4. Tumor directly invading the critical area to be spared (for example a patient with tumor invading a critical white matter tract; ineligible for cognitive-sparing)\n5. Planned chemotherapy during SRS (on the day of SRS)\n6. Previous whole brain radiation therapy\n7. Leptomeningeal metastases (ineligible for SRS)\n8. Metastases from primary germ cell tumor, small cell carcinoma, or primary CNS lymphoma (ineligible for SRS)","ALL","18 Years",{"count":70,"type":71},60,"ESTIMATED","INTERVENTIONAL",[74],"PHASE2",[76,77,78],"Brain Metastases, Adult","Neurocognitive Function","Cancer","2026-06-09",{"date":81,"type":82},"2026-06-10","ACTUAL",{"date":84,"type":82},"2019-05-01",{"date":86,"type":71},"2028-12-31",{"name":51,"class":6},1]